IL6 and plasma cell myeloma: Furthermore, MGUS is at the most stable end of the multiple myeloma spectrum, proliferating at a low rate until a second “hit” triggers malignant transformation, such as IL-6 stimulation, which has been shown to increase the amount of the monoclonal protein produced by plasma cells and inhibit albumin synthesis in the liver simultaneously [35–38].